Miguel A. Garcia-Sanchez

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Reversal of lung consolidation with mechanical insufflation-exsufflation in a brain-dead lung donor.

Reversal of lung consolidation with mechanical insufflation-exsufflation in a brain-dead lung donor.

Journal: JHLT open

Published: May 11, 2026

On-scene selective brain cooling in ventricular fibrillation cardiac arrest: pilot results from the PRINCESS2 randomised trial.

On-scene selective brain cooling in ventricular fibrillation cardiac arrest: pilot results from the PRINCESS2 randomised trial.

Journal: Critical care (London, England)

Published: December 09, 2025

RAPID-CARE: Rapid Antibiotic Optimization in the ICU After Implementation of a Pneumonia Multiplex PCR Test-A Real-World Evaluation.

RAPID-CARE: Rapid Antibiotic Optimization in the ICU After Implementation of a Pneumonia Multiplex PCR Test-A Real-World Evaluation.

Journal: Antibiotics (Basel, Switzerland)

Published: September 13, 2025

Oral Melatonin in Critically Ill Patients With COVID-19: A Quasi-Experimental Pragmatic Trial.

Oral Melatonin in Critically Ill Patients With COVID-19: A Quasi-Experimental Pragmatic Trial.

Journal: Journal of medical virology

Published: July 18, 2025

Automated atomic site determination by four-dimensional scanning transmission electron microscopy data analytics.

Automated atomic site determination by four-dimensional scanning transmission electron microscopy data analytics.

Journal: Ultramicroscopy

Published: May 27, 2025

Pathogen-specific host response in critically ill patients with blood stream infections: a nested case-control study.

Pathogen-specific host response in critically ill patients with blood stream infections: a nested case-control study.

Journal: EBioMedicine

Published: December 15, 2024

Effectiveness and safety of cefiderocol treatment in patients with Gram-negative bacterial infections in Spain in the early access programme: results of the PERSEUS study.

Effectiveness and safety of cefiderocol treatment in patients with Gram-negative bacterial infections in Spain in the early access programme: results of the PERSEUS study.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: November 05, 2024

Effect of mesenchymal stem cells on the host response in severe community-acquired pneumonia.

Effect of mesenchymal stem cells on the host response in severe community-acquired pneumonia.

Journal: Thorax

Published: September 25, 2024

Comparison of Mechanical Insufflation-Exsufflation and Hypertonic Saline and Hyaluronic Acid With Conventional Open Catheter Suctioning in Intubated Patients.

Comparison of Mechanical Insufflation-Exsufflation and Hypertonic Saline and Hyaluronic Acid With Conventional Open Catheter Suctioning in Intubated Patients.

Journal: Respiratory care

Published: February 02, 2024

The safety and efficacy of stem cells for the treatment of severe community-acquired bacterial pneumonia: A randomized clinical trial.

The safety and efficacy of stem cells for the treatment of severe community-acquired bacterial pneumonia: A randomized clinical trial.

Journal: Journal of critical care

Published: July 27, 2023

Impact of the "Zero Resistance" program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study.

Impact of the "Zero Resistance" program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study.

Journal: Medicina intensiva

Published: September 28, 2022

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial.

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial.

Journal: Critical care (London, England)

Published: September 12, 2022

Showing 1-12 of 35

Last Updated: 09/26/2026